Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Alnylam Pharmaceuticals (NQ: ALNY ) 277.33 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Alnylam Pharmaceuticals < Previous 1 2 3 4 5 6 7 8 9 ... 14 15 Next > The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree June 02, 2023 Big Pharma is facing a patent cliff that could siphon off billions in revenue. Via Investor's Business Daily What 10 Analyst Ratings Have To Say About Alnylam Pharmaceuticals May 31, 2023 Via Benzinga Analyst Says Alnylam's New Patisiran Data Shows Disease Slowing With Early Intervention, But Survival Benefit Remains Of Interest May 22, 2023 Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) released new results from an interim analysis of exploratory data from the open-label extension (OLE) period of the APOLLO-B Phase 3 study of patisiran, for... Via Benzinga Alnylam Presents 18-Month Results from the APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with Cardiomyopathy May 20, 2023 From Alnylam Via Business Wire Looking Into Alnylam Pharmaceuticals's Recent Short Interest May 10, 2023 Via Benzinga $1000 Invested In This Stock 15 Years Ago Would Be Worth $7,600 Today May 05, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2023 May 05, 2023 Via Benzinga Where Alnylam Pharmaceuticals Stands With Analysts May 05, 2023 Via Benzinga Alnylam Clocks ~50% Revenue Growth In Q1 On Solid Commercial Execution May 04, 2023 Via Benzinga Alnylam Pharmaceuticals Reports First Quarter 2023 Financial Results and Highlights Recent Period Activity May 04, 2023 From Alnylam Pharmaceuticals, Inc. Via Business Wire How To Attend Alnylam Pharmaceuticals Q1 2023 Earnings Conference Call April 21, 2023 Via Benzinga $1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today April 17, 2023 Via Benzinga Alnylam to Webcast Presentation at BofA Securities 2023 Health Care Conference May 03, 2023 From Alnylam Pharmaceuticals, Inc. Via Business Wire Alnylam Issues 2022 Corporate Responsibility Report May 03, 2023 From Alnylam Pharmaceuticals, Inc. Via Business Wire Alnylam - Regeneron Partnered Alzheimer's Candidate's Initial Data Sounds Promising, Analyst Says April 27, 2023 Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) and its partner Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Via Benzinga A Bearish Sign Appears On Alnylam Pharmaceuticals's Chart April 11, 2023 Via Benzinga Here's How Much $100 Invested In Alnylam Pharmaceuticals 5 Years Ago Would Be Worth Today April 05, 2023 Via Benzinga Analyst Ratings for Alnylam Pharmaceuticals March 21, 2023 Via Benzinga Alnylam and Regeneron Report Positive Interim Phase 1 Clinical Data on ALN-APP, an Investigational RNAi Therapeutic for Alzheimer’s Disease and Cerebral Amyloid Angiopathy April 26, 2023 From Alnylam Pharmaceuticals, Inc. Via Business Wire Regeneron and Alnylam Report Positive Interim Phase 1 Clinical Data on ALN-APP, an Investigational RNAi Therapeutic for Alzheimer’s Disease and Cerebral Amyloid Angiopathy April 26, 2023 From Regeneron Pharmaceuticals, Inc. Via GlobeNewswire Why Legend Biotech Stock Is Having Its Best Month Yet April 25, 2023 With the biotech market’s focus back on treatments for cancer and other life-threatening diseases, Legend has now tripled off its bottom to a record high. Via MarketBeat 3 Pharma Stocks That Could See a Surge in Demand in 2023 April 24, 2023 These pharma stocks to buy are poised for long-term growth in the trillion-dollar biotechnology space, offering tremendous upside ahead Via InvestorPlace Alnylam to Webcast Conference Call Discussing First Quarter 2023 Financial Results April 20, 2023 From Alnylam Pharmaceuticals, Inc. Via Business Wire 10 Health Care Stocks With Whale Alerts In Today's Session April 19, 2023 Via Benzinga Analyst Upgrades Arrowhead Pharma Citing 'Attractive Risk/Reward' April 12, 2023 SVB Securities upgraded Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) to Outperform from Market Perform on attractive risk-reward following shares' underperformance relative to larger cap oligo therapy... Via Benzinga Pfizer Slapped With Additional Patent Infringement Lawsuit Over Its Famed COVID-19 Shots April 04, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023 March 21, 2023 Via Benzinga 3 Growth Stocks That Could Disrupt the Healthcare Industry March 13, 2023 These healthcare growth stocks will continue to provide steady and consistent returns, rewarding smart investors over time. Via InvestorPlace Alnylam Announces Appointment of Peter Kellogg to Board of Directors March 08, 2023 From Alnylam Pharmaceuticals, Inc. Via Business Wire Looking Into Alnylam Pharmaceuticals's Recent Short Interest March 03, 2023 Alnylam Pharmaceuticals's (NASDAQ:ALNY) short percent of float has fallen 5.3% since its last report. The company recently reported that it has 5.10 million shares sold short, which is 4.82% of all... Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 14 15 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.